Streamex Corp. — Director's Dealing 2022

Apr 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2022-03-30

Reporting Person: CHAUSSY STEVE (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-30	Restricted Stock	$	A	200000	Acquired		Common Stock (200000)	Direct

Footnotes

F1: The shares of restricted stock shall be fully vested as of March 30, 2022, the date of the grant.